Page last updated: 2024-12-10
15,16-dihydrobiliverdin ixa
Description
15,16-Dihydrobiliverdin ixa, also known as **dihydrobiliverdin IXα**, is a **bilin**, a type of open-chain tetrapyrrole molecule. It is a **reduced form of biliverdin IXα**, a green pigment found in the breakdown of heme, the iron-containing molecule in red blood cells.
Here's why it's important for research:
**1. Potential therapeutic applications:**
* **Antioxidant properties:** Dihydrobiliverdin IXα has been shown to possess antioxidant properties, potentially protecting cells from damage caused by free radicals. This makes it a potential therapeutic target for conditions like oxidative stress and neurodegenerative diseases.
* **Anti-inflammatory effects:** Studies suggest that dihydrobiliverdin IXα has anti-inflammatory properties, potentially contributing to the reduction of inflammation in various diseases.
* **Anti-cancer activity:** There is some preliminary evidence indicating that dihydrobiliverdin IXα might possess anti-cancer properties, potentially impacting cancer cell growth and survival.
**2. Understanding heme metabolism and biliverdin IXα function:**
* **Studying the reduction of biliverdin IXα:** Understanding the enzymatic process that converts biliverdin IXα to dihydrobiliverdin IXα is crucial for comprehending heme metabolism and the role of biliverdin IXα in various physiological processes.
* **Investigating its role in health and disease:** Researching the specific mechanisms of action of dihydrobiliverdin IXα in biological systems can contribute to understanding its role in maintaining health and its potential involvement in disease development.
**3. Developing novel diagnostic tools:**
* **Monitoring heme metabolism:** Due to its close connection with biliverdin IXα, dihydrobiliverdin IXα could be used as a potential biomarker to monitor heme metabolism and identify abnormalities in this process.
**4. Studying the evolution of tetrapyrrole biosynthesis:**
* **Understanding ancestral pigment molecules:** Dihydrobiliverdin IXα serves as a model molecule for studying the evolution of tetrapyrrole biosynthesis, contributing to understanding the origins and development of these important molecules in living organisms.
Overall, 15,16-dihydrobiliverdin IXα holds significant potential for various research areas, ranging from understanding fundamental biological processes to developing novel therapeutic strategies and diagnostic tools. However, more research is required to fully understand its properties and potential applications.
15,16-dihydrobiliverdin IXa: partially reduced intermediate in the formation of phycobilins for biliverdin IXa; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
Synonyms (7)
Synonym |
3-[(2z,5z)-2-[[3-(2-carboxyethyl)-5-[[(2r)-4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid |
CHEBI:181358 |
8,12-bis(2-carboxyethyl)-3,18-ethenyl-2,7,13,17-tetramethyl-15,16-dihydrobilin-1,19(21h,24h)-dione |
CHEBI:16790 |
137429-14-2 |
15,16-dihydrobiliverdin ixalpha |
15,16-dihydrobiliverdin ixa |
Drug Classes (1)
Class | Description |
biladienes | Compounds based on a biladiene skeleton. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.56 (24.57) | Research Supply Index | 1.95 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |